Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL LUNG CANCER SURGERY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 PRODUCT TYPE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 EPIDEMIOLOGY
5.1 INCIDENCE OF LUNG CANCER, BY COUNTRY
5.2 TREATMENT RATE BY GENDER
5.3 MORTALITY BY GENDER
6 REGULATIONS OF THE GLOBAL LUNG CANCER SURGERY MARKET
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASED PREVALENCE OF LUNG CANCER DISEASES
7.1.2 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE
7.1.3 INCREASED AWARENESS REGARDING THE BENEFITS
7.1.4 GOVERNMENT INITIATIVES TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES
7.1.5 RISE IN AIR POLLUTION AND SURGE IN SMOKING
7.2 RESTRAINTS
7.2.1 HIGH COST OF LUNG CANCER SURGERY
7.2.2 INSUFFICIENT FUNDING FOR CANCER AND ASSOCIATED DISORDERS
7.2.3 STRINGENT REGULATORY FRAMEWORKS
7.3 OPPORTUNITIES
7.3.1 RISE OF MINIMALLY INVASIVE TECHNIQUES IN LUNG CANCER SURGERY
7.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS
7.3.3 INCREASE IN RESEARCH AND DEVELOPMENT EFFORTS IN THE HEALTHCARE INDUSTRY
7.4 CHALLENGES
7.4.1 DEARTH OF SKILLED ONCOLOGISTS
7.4.2 HEALTH RISK OF LUNG CANCER SURGERIES
8 GLOBAL LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 SURGICAL INSTRUMENTS
8.2.1 HAND INSTRUMENTS
8.2.1.1 STAPLER
8.2.1.2 FORCEPS
8.2.1.3 ELECTRIC HOOK
8.2.1.4 RETRACTORS
8.2.1.5 CLAMPS
8.2.1.6 SCISSORS
8.2.1.7 ELEVATORS
8.2.1.8 HEMOCLIP APPLIERS
8.2.1.9 ULTRASOUND SCALPEL
8.2.1.10 RIB SHEARS
8.2.1.11 CUTTERS
8.2.1.12 NEEDLE HOLDER
8.2.1.13 TROCAR
8.2.1.14 OTHERS
8.2.2 POWERED SURGICAL EQUIPMENT
8.2.2.1 ADVANCED ENERGY INSTRUMENTS
8.2.2.1.1 ADVANCED BIPOLAR INSTRUMENTS
8.2.2.1.2 OTHERS
8.2.2.2 BASIC ENERGY INSTRUMENTS
8.2.2.2.1 BIPOLAR INSTRUMENTS
8.2.2.2.2 MONOPOLAR INSTRUMENTS
8.3 MONITORING & VISUALISING SYSTEM
8.3.1 CAMERAS & VIDEO SUPPORT
8.3.2 BRONCHOSCOPES
8.3.3 ENDOSCOPIC TROCARS WITH OPTICAL VIEWS
8.3.4 THORACOSCOPES
8.3.5 MEDIASTINOSCOPES
8.3.6 OTHERS
8.4 ENDOSURGICAL EQUIPMENTS
8.5 ROBOTIC ASSISTED SURGERY SYSTEMS
8.6 OTHERS
9 GLOBAL LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE
9.1 OVERVIEW
9.2 THORACOTOMY
9.2.1 LOBECTOMY
9.2.1.1 SURGICAL INSTRUMENTS
9.2.1.2 MONITORING & VISUALISING SYSTEMS
9.2.1.3 ENDOSURGICAL EQUIPMENT
9.2.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.1.5 OTHERS
9.2.2 SLEEVE RESECTION
9.2.2.1 SURGICAL INSTRUMENTS
9.2.2.2 MONITORING & VISUALISING SYSTEMS
9.2.2.3 ENDOSURGICAL EQUIPMENT
9.2.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.2.5 OTHERS
9.2.3 SEGMENTECTOMY
9.2.3.1 SURGICAL INSTRUMENTS
9.2.3.2 MONITORING & VISUALISING SYSTEMS
9.2.3.3 ENDOSURGICAL EQUIPMENT
9.2.3.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.3.5 OTHERS
9.2.4 PNEUMONECTOMY
9.2.4.1 SURGICAL INSTRUMENTS
9.2.4.2 MONITORING & VISUALISING SYSTEMS
9.2.4.3 ENDOSURGICAL EQUIPMENT
9.2.4.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.4.5 OTHERS
9.2.5 OTHERS
9.3 MINIMALLY INVASIVE SURGERIES
9.3.1 VIDEO-ASSISTED THORACIC SURGERY (VATS)
9.3.1.1 SURGICAL INSTRUMENTS
9.3.1.2 MONITORING & VISUALISING SYSTEMS
9.3.1.3 ENDOSURGICAL EQUIPMENT
9.3.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.3.1.5 OTHERS
9.3.2 ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS)
9.3.2.1 SURGICAL INSTRUMENTS
9.3.2.2 MONITORING & VISUALISING SYSTEMS
9.3.2.3 ENDOSURGICAL EQUIPMENT
9.3.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.3.2.5 OTHERS
10 GLOBAL LUNG CANCER SURGERY MARKET, BY PATIENT TYPE
10.1 OVERVIEW
10.2 MALE
10.2.1 GERIATRIC
10.2.1.1 THORACOTOMY
10.2.1.2 MINIMALLY INVASIVE SURGERIES
10.2.2 ADULTS
10.2.2.1 THORACOTOMY
10.2.2.2 MINIMALLY INVASIVE SURGERIES
10.2.3 PEDIATRIC
10.2.3.1 THORACOTOMY
10.2.3.2 MINIMALLY INVASIVE SURGERIES
10.3 FEMALE
10.3.1 GERIATRIC
10.3.1.1 THORACOTOMY
10.3.1.2 MINIMALLY INVASIVE SURGERIES
10.3.2 ADULTS
10.3.2.1 THORACOTOMY
10.3.2.2 MINIMALLY INVASIVE SURGERIES
10.3.3 PEDIATRIC
10.3.3.1 THORACOTOMY
10.3.3.2 MINIMALLY INVASIVE SURGERIES
11 GLOBAL LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.4 ONLINE SALES
11.5 OTHERS
12 GLOBAL LUNG CANCER SURGERY MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 PUBLIC HOSPITALS
12.2.2 PRIVATE HOSPITALS
12.3 AMBULATORY SURGICAL CENTERS
12.4 SPECIALTY CANCER CARE CENTERS
12.5 ACADEMIC AND RESEARCH LABORATORIES
12.6 OTHERS
13 GLOBAL LUNG CANCER SURGERY MARKET, BY REGION
13.1 OVERVIEW
13.2 NORTH AMERICA
13.2.1 U.S
13.2.2 CANADA
13.2.3 MEXICO
13.3 EUROPE
13.3.1 GERMANY
13.3.2 FRANCE
13.3.3 U.K.
13.3.4 ITALY
13.3.5 SPAIN
13.3.6 RUSSIA
13.3.7 TURKEY
13.3.8 BELGIUM
13.3.9 NETHERLANDS
13.3.10 SWITZERLAND
13.3.11 REST OF EUROPE
13.4 ASIA-PACIFIC
13.4.1 CHINA
13.4.2 JAPAN
13.4.3 INDIA
13.4.4 SOUTH KOREA
13.4.5 AUSTRALIA
13.4.6 SINGAPORE
13.4.7 THAILAND
13.4.8 MALAYSIA
13.4.9 INDONESIA
13.4.10 PHILIPPINES
13.4.11 REST OF ASIA-PACIFIC
13.5 SOUTH AMERICA
13.5.1 BRAZIL
13.5.2 ARGENTINA
13.5.3 REST OF SOUTH AMERICA
13.6 MIDDLE EAST AND AFRICA
13.6.1 SAUDI ARABIA
13.6.2 SOUTH AFRICA
13.6.3 UAE
13.6.4 ISRAEL
13.6.5 EGYPT
13.6.6 REST OF MIDDLE EAST AND AFRICA
14 GLOBAL LUNG CANCER SURGERY MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
14.3 COMPANY SHARE ANALYSIS: EUROPE
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILES
16.1 JOHNSON & JOHNSON SERVICES, INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 ACCURAY INCORPORATED
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 INTUITIVE SURGICAL
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 FUJIFILM HOLDINGS CORPORATION
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 AMBU A/S.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 ANGIODYNAMICS
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENT
16.7 ACKERMANN
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 ASAP ENDOSCOPIC PRODUCTS GMBH
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCTPORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 FUSIONKRAFT
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 GERMED USA
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 KLS MARTIN GROUP
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 KARL STORZ SE & CO. KG
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 MEDTRONICS (2021)
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENT
16.15 OLYMPUS CORPORATION
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCTPORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 RICHARD WOLF GMBH.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENTS
16.17 SURGICAL HOLDINGS
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 SONTEC INSTRUMENTS, INC.
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 SCANLAN INTERNATIONAL
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 TELEFLEX INCORPORATED
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 PRODUCTPORTFOLIO
16.20.4 RECENT DEVELOPMENT
16.21 TROKAMED GMBH.
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 WEXLER SURGICAL
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 THE BELOW TABLE SHOWS REGION-SPECIFIC INCIDENCE AGE-STANDARDIZED RATES PER 100,000 BY SEX FOR LUNG CANCER AMONG MEN AND WOMEN IN 2020
TABLE 2 GLOBAL LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 3 GLOBAL SURGICAL INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 GLOBAL SURGICAL INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 5 GLOBAL HAND INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 GLOBAL HAND INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 7 GLOBAL POWERED SURGICAL EQUIPMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 8 GLOBAL ADVANCED ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 9 GLOBAL BASIC ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 10 GLOBAL BASIC ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 11 GLOBAL MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 GLOBAL MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 13 GLOBAL MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 14 GLOBAL ENDOSURGICAL EQUIPMENT IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 GLOBAL ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 GLOBAL OTHERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 GLOBAL LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 18 GLOBAL THORACOTOMY IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 GLOBAL THORACOTOMY IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 20 GLOBAL LOBECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 21 GLOBAL SLEEVE RESECTION IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 22 GLOBAL SEGMENTECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 23 GLOBAL PNEUMONECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 24 GLOBAL MINIMALLY INVASIVE SURGERIES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 GLOBAL MINIMALLY INVASIVE SURGERIES IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 26 GLOBAL VIDEO-ASSISTED THORACIC SURGERY (VATS) IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 27 GLOBAL ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS) IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 28 GLOBAL LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 29 GLOBAL MALE IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 GLOBAL MALE IN LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 31 GLOBAL GERIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 32 GLOBAL ADULTS IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 33 GLOBAL PEDIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 34 GLOBAL FEMALE IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 GLOBAL FEMALE IN LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 36 GLOBAL GERIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 37 GLOBAL ADULTS IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 38 GLOBAL PEDIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 39 GLOBAL LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 40 GLOBAL DIRECT TENDER IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 GLOBAL RETAIL SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 42 GLOBAL ONLINE SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 GLOBAL ONLINE SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 44 GLOBAL LUNG CANCER SURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 45 GLOBAL HOSPITALS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 46 GLOBAL HOSPITALS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 47 GLOBAL AMBULATORY SURGICAL CENTERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 48 GLOBAL SPECIALTY CANCER CARE CENTERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 GLOBAL ACADEMIC AND RESEARCH LABORATORIES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION))
TABLE 50 GLOBAL OTHERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 GLOBAL LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 52 NORTH AMERICA LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 53 EUROPE LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 54 ASIA-PACIFIC LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 55 SOUTH AMERICA LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 56 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 GLOBAL LUNG CANCER SURGERYMARKET: SEGMENTATION
FIGURE 2 GLOBAL LUNG CANCER SURGERY MARKET: GEOGRAPHIC SCOPE
FIGURE 3 GLOBAL LUNG CANCER SURGERYMARKET: DATA TRIANGULATION
FIGURE 4 GLOBAL LUNG CANCER SURGERY MARKET: SNAPSHOT
FIGURE 5 GLOBAL LUNG CANCER SURGERY MARKET: BOTTOM UP APPROACH
FIGURE 6 GLOBAL LUNG CANCER SURGERY MARKET: TOP DOWN APPROACH
FIGURE 7 GLOBAL LUNG CANCER SURGERY MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 GLOBAL LUNG CANCER SURGERY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL LUNG CANCER SURGERY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL LUNG CANCER SURGERY MARKET: END USER COVERAGE GRID
FIGURE 11 GLOBAL LUNG CANCER SURGERY MARKET SEGMENTATION
FIGURE 12 GROWING PREVALENCE OF CANCER DISEASES, RISE IN AIR POLLUTION, AND SURGE IN SMOKING HABIT IS EXPECTED TO DRIVE THE GLOBAL LUNG CANCER SURGERY MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 SURGICAL INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL LUNG CANCER SURGERY MARKET IN 2022 & 2029
FIGURE 14 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE LUNG CANCER SURGERY MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH A STRONG CAGR IN THE FORECAST PERIOD FROM 2022 TO 2029
FIGURE 15 NORTH AMERICA IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKET FOR THE GLOBAL LUNG CANCER SURGERY MARKET IN THE FORECAST PERIOD FROM 2022 TO 2029
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL LUNG CANCER SURGERY MARKET
FIGURE 17 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2021
FIGURE 18 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 19 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 20 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 21 GLOBAL LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2021
FIGURE 22 GLOBAL LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2022-2029 (USD MILLION)
FIGURE 23 GLOBAL LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, CAGR (2022-2029)
FIGURE 24 GLOBAL LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, LIFELINE CURVE
FIGURE 25 GLOBAL LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2021
FIGURE 26 GLOBAL LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2022-2029 (USD MILLION)
FIGURE 27 GLOBAL LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, CAGR (2022-2029)
FIGURE 28 GLOBAL LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 29 GLOBAL LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 30 GLOBAL LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 31 GLOBAL LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 32 GLOBAL LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 33 GLOBAL LUNG CANCER SURGERY MARKET: BY END USER, 2021
FIGURE 34 GLOBAL LUNG CANCER SURGERY MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 35 GLOBAL LUNG CANCER SURGERY MARKET: BY END USER, CAGR (2022-2029)
FIGURE 36 GLOBAL LUNG CANCER SURGERY MARKET: BY END USER, LIFELINE CURVE
FIGURE 37 GLOBAL LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 38 GLOBAL LUNG CANCER SURGERY MARKET: BY REGION (2021)
FIGURE 39 GLOBAL LUNG CANCER SURGERY MARKET: BY REGION (2022 & 2029)
FIGURE 40 GLOBAL LUNG CANCER SURGERY MARKET: BY REGION (2021 & 2029)
FIGURE 41 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 42 NORTH AMERICA LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 43 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)
FIGURE 44 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 45 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 46 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 47 EUROPE LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 48 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)
FIGURE 49 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 50 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 51 EUROPE LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 52 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 53 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)
FIGURE 54 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 55 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 56 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 57 SOUTH AMERICA LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 58 SOUTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)
FIGURE 59 SOUTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 60 SOUTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 61 SOUTH AMERICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 62 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 63 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)
FIGURE 64 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 65 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 66 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 67 GLOBAL LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%)
FIGURE 68 NORTH AMERICA LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%)
FIGURE 69 EUROPE LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%)
FIGURE 70 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%)
